Test Price
2,800 AED✅ Home Collection Available
TNNT1 Gene Nemaline Myopathy Type 5 Genetic Test in UAE
Executive Summary & Core Metrics
99.9% Diagnostic Sensitivity – ISO 9001:2015 certified NGS workflow ensures ultra-accurate variant detection across the entire TNNT1 coding region and splice sites.
Premium Logistical Care – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM for standard blood specimens.
Clinical Guidance – Telephonic post-test consultation with a DHA-licensed Consultant Medical Geneticist for comprehensive result interpretation and family planning advice.
Insurance & Billing – Direct billing verification via WhatsApp: +971 54 548 8731. Our team handles pre-approvals and documentation.
This comprehensive genetic screening for the TNNT1 gene provides accurate diagnosis of nemaline myopathy type 5 with integrated genetic counselling and certified home collection across the UAE.
Test Overview & Methodology
The TNNT1 Next-Generation Sequencing test is a comprehensive genetic analysis that screens for pathogenic variants in the troponin T1 gene, responsible for nemaline myopathy type 5 – a rare congenital muscle disorder characterized by muscle weakness, hypotonia, and respiratory involvement. The NGS method reads the entire coding region and flanking splice sites, ensuring even rare or novel variants are detected with high confidence.
| Feature | Our NGS Test | Closest Alternative (Sanger / Panel) |
|---|---|---|
| Methodology | Next-Generation Sequencing (entire coding region ± splice sites) | Sanger sequencing (single exon) or targeted panel with limited gene coverage |
| Diagnostic Sensitivity | 99.9% (detects novel and deep intronic variants) | ~85% – misses copy number variants and deep intronic mutations |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Price (AED) | 2,800 | ~3,500+ |
* Home collection and genetic counselling included in our package.
Physician Insight & Safety Protocols
"As a DHA-licensed Consultant Medical Geneticist, I emphasize that a genetic test is a critical component of the diagnostic pathway but must always be interpreted alongside clinical examination and detailed family history. A negative result does not exclude the condition if symptoms persist, and patients must never alter or discontinue prescribed medications without direct physician guidance. The safety and wellbeing of every individual undergoing genetic testing is our foremost responsibility."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Notice
Do not discontinue any prescribed medication without consulting your treating physician. Genetic test results should be reviewed in conjunction with a complete medical history and current clinical status.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Active bleeding disorder or severe coagulopathy that contraindicates venipuncture – alternative dried blood spot collection is available upon assessment.
- Exclusion: Minors without parental or guardian consent – mandatory genetic counselling session required prior to sample collection per UAE regulatory standards.
- Emergency Red Flag: Sudden respiratory distress, inability to swallow, or profound acute muscle weakness – seek immediate hospital care, do not proceed with elective testing.
- Emergency Red Flag: Acute loss of consciousness or seizures – testing should be deferred until the patient is clinically stable under specialist supervision.
Patient FAQ & Clinical Guidance
1. What does the TNNT1 gene test detect?
Quick Answer: It identifies pathogenic DNA variants in the TNNT1 gene linked to nemaline myopathy type 5, a congenital muscle disease characterized by weakness and hypotonia.
The NGS method reads the entire coding region and flanking splice sites, ensuring even rare or novel variants are captured. This genetic confirmation guides accurate diagnosis, prognosis estimation, and informed family planning decisions.
2. How is the sample collected for this genetic test?
Quick Answer: A simple blood draw or a painless finger-prick dried blood spot on an FTA card is collected by our DHA-licensed phlebotomist during a scheduled home visit.
The mobile team arrives within your preferred window between 8 AM and 11 PM. All specimens are transported under ISO-certified cold-chain conditions to preserve DNA integrity for accurate sequencing.
3. When will I receive my results and what guidance is provided?
Quick Answer: Results are ready within 3–4 weeks, followed by a complimentary telephonic post-test consultation with a clinical geneticist who explains the findings in plain language.
You will receive a secure digital report with actionable interpretation. Our geneticist discusses recommended follow-up steps with your neurologist or paediatrician and addresses any questions about variant significance or reproductive implications.
4. Is genetic counselling mandatory before the test?
Quick Answer: Yes, a pre-test genetic counselling session is required to document family history, draw a pedigree chart, and ensure informed consent as per UAE regulations.
This session ensures accurate variant interpretation and respects the principles of informed decision-making and data privacy under UAE health data protection laws.
UAE Regulatory & Data Privacy Adherence
This service operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. All genetic data is processed within DHA-licensed facilities under strict confidentiality protocols. ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | TNNT1 Gene Nemaline Myopathy Type 5 Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot on FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) – Full Coding Region ± Splice Sites |
| ICD-10-CM Code | G71.2 (Congenital myopathy, nemaline type) |
| LOINC Code | 55233-1 (Genetic analysis overall) |
| DHA Facility License & Laboratory Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians